EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

DKK1 in Cancer: A Bench-to-Bedside Review of Molecular Mechanisms and Clinical Applications

Meiheng Sun, Yuzhe Wang, Yihao Zhang, Ziqi Chen, Yuanyuan Yu, Aiping Lu, Wei Kang iD, Qianjun Chen, Ge Zhang iD, Jianhui Tian, Bao-Ting Zhang

Cancers · 25.04.2026 · 18 (9) · 1375

DOI: 10.3390/cancers18091375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.04.2026. Verfasst von Meiheng Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dickkopf-1 (DKK1) is a secreted glycoprotein that traditionally acts as an antagonist of canonical Wnt/β-catenin signaling. Although it functions as a tumor suppressor in some specific biological background and disease stages, growing evidence links DKK1 to tumor progression, immune evasion, and therapy resistance in a variety of multiple malignancies. This review provides a comprehensive bench-to-bedside overview of DKK1 in cancer. We first delineate how DKK1 regulates both Wnt-dependent and Wnt-independent pathways. From a clinical perspective, we evaluate the application potential of DKK1 as a diagnostic and prognostic biomarker. We further discuss the progress of DKK1-targeted interventions, ranging from monoclonal antibodies in clinical trials to next-generation therapeutic modalities. Finally, we discuss the challenges in clinical translation and suggest future directions for DKK1-based precision medicine. In summary, by integrating preclinical insights with current clinical data, this review provides a strategic roadmap for advancing DKK1-targeted therapies in cancer.

Schlagwörter

Stichwörter der Autor:innen

Dickkopf-1cancerclinical trailsmechanismtargeted therapy

Autor:innen und Institutionen

  • School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Oncology, Shanghai Municipal Hospital of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.
  • Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University, Hong Kong, China.
  • Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.

ORCID-Profile: Wei Kang, Ge Zhang

Zitieren

APA

Sun, M., Wang, Y., Zhang, Y., Chen, Z., Yu, Y., Lu, A., Kang, W., Chen, Q., Zhang, G., Tian, J., & Zhang, B. T. (2026). DKK1 in Cancer: A Bench-to-Bedside Review of Molecular Mechanisms and Clinical Applications. Cancers, 18(9), 1375. https://doi.org/10.3390/cancers18091375

Vancouver

Sun M, Wang Y, Zhang Y, Chen Z, Yu Y, Lu A, et al. DKK1 in Cancer: A Bench-to-Bedside Review of Molecular Mechanisms and Clinical Applications. Cancers. 2026;18(9):1375. doi:10.3390/cancers18091375

BibTeX
@article{Sun2026,
  author = {Sun, Meiheng and Wang, Yuzhe and Zhang, Yihao and Chen, Ziqi and Yu, Yuanyuan and Lu, Aiping and Kang, Wei and Chen, Qianjun and Zhang, Ge and Tian, Jianhui and Zhang, Bao-Ting},
  title = {DKK1 in Cancer: A Bench-to-Bedside Review of Molecular Mechanisms and Clinical Applications},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1375},
  doi = {10.3390/cancers18091375}
}
Kostenlos starten →